Intellia Therapeutics, Inc. - NTLA
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 03, 2026 | EVP, Chief Technical Officer | A | A | 10,505.0 | 0.0 | 0.0 | 10,505.0 | View | |
| Mar 03, 2026 | EVP, Chief Technical Officer | S | D | 607.0 | 13.78 | 8,364.46 | 93,864.0 | View | |
| Mar 03, 2026 | EVP, Chief Technical Officer | A | A | 7,353.0 | 0.0 | 0.0 | 94,471.0 | View | |
| Mar 03, 2026 | EVP, Chief Scientific Officer | A | A | 56,000.0 | 0.0 | 0.0 | 56,000.0 | View | |
| Mar 03, 2026 | EVP, Chief Scientific Officer | A | A | 39,200.0 | 0.0 | 0.0 | 137,733.0 | View | |
| Mar 03, 2026 | EVP, Chief Financial Officer | A | A | 87,543.0 | 0.0 | 0.0 | 87,543.0 | View | |
| Mar 03, 2026 | EVP, Chief Financial Officer | A | A | 61,280.0 | 0.0 | 0.0 | 160,963.0 | View | |
| Mar 03, 2026 | EVP, Chief Medical Officer | A | A | 14,204.0 | 0.0 | 0.0 | 14,204.0 | View | |
| Mar 03, 2026 | EVP, Chief Medical Officer | A | A | 9,943.0 | 0.0 | 0.0 | 131,192.0 | View | |
| Mar 03, 2026 | EVP, General Counsel | A | A | 65,829.0 | 0.0 | 0.0 | 65,829.0 | View | |
| Mar 03, 2026 | EVP, General Counsel | S | D | 1,211.0 | 13.78 | 16,687.58 | 156,794.0 | View | |
| Mar 03, 2026 | EVP, General Counsel | A | A | 46,080.0 | 0.0 | 0.0 | 158,005.0 | View | |
| Mar 03, 2026 | President and CEO | A | A | 225,400.0 | 0.0 | 0.0 | 225,400.0 | View | |
| Mar 03, 2026 | President and CEO | A | A | 156,400.0 | 0.0 | 0.0 | 1,169,739.0 | View | |
| Mar 03, 2026 | VP, Chief Accounting Officer | A | A | 17,250.0 | 0.0 | 0.0 | 69,527.0 | View | |
| Jan 07, 2026 | VP, Chief Accounting Officer | S | D | 2,989.0 | 9.21 | 27,528.69 | 52,277.0 | View | |
| Jan 07, 2026 | EVP, Chief Financial Officer | S | D | 6,379.0 | 9.21 | 58,750.59 | 99,683.0 | View | |
| Jan 07, 2026 | EVP, Chief Technical Officer | S | D | 9,515.0 | 9.21 | 87,633.15 | 87,118.0 | View | |
| Jan 07, 2026 | EVP, Chief Medical Officer | S | D | 11,903.0 | 9.21 | 109,626.63 | 121,249.0 | View | |
| Jan 07, 2026 | President and CEO | S | D | 34,146.0 | 9.21 | 314,484.66 | 1,013,339.0 | View | |
| Jan 07, 2026 | EVP, Chief Scientific Officer | S | D | 8,508.0 | 9.21 | 78,358.68 | 98,533.0 | View | |
| Jan 07, 2026 | EVP, General Counsel | S | D | 10,397.0 | 9.21 | 95,756.37 | 101,528.0 | View | |
| Jan 07, 2026 | — | P | A | 150,000.0 | 9.35 | 1,402,500.0 | 207,453.0 | View | |
| Dec 12, 2025 | President and CEO | M | D | 8,557.0 | 0.0 | 0.0 | 0.0 | View | |
| Dec 12, 2025 | President and CEO | M | D | 49,959.0 | 0.0 | 0.0 | 8,557.0 | View | |
| Dec 12, 2025 | President and CEO | M | A | 8,557.0 | 6.83 | 58,444.31 | 1,047,485.0 | View | |
| Dec 12, 2025 | President and CEO | S | D | 5,355.0 | 9.59 | 51,354.45 | 1,038,928.0 | View | |
| Dec 12, 2025 | President and CEO | S | D | 32,832.0 | 9.47 | 310,919.04 | 1,044,283.0 | View | |
| Dec 12, 2025 | President and CEO | S | D | 49,959.0 | 9.49 | 474,110.91 | 1,077,115.0 | View | |
| Dec 12, 2025 | President and CEO | M | A | 49,959.0 | 6.83 | 341,219.97 | 1,127,074.0 | View |